Abreu-Silva R S, Lezirovitz K, Braga M C C, Spinelli M, Pirana S, Della-Rosa V A, Otto P A, Mingroni-Netto R C
Centro de Estudos do Genoma Humano, Departamento de Genética e Biologia Evolutiva, Instituto de Biociências, Universidade de São Paulo, São Paulo, SP, Brazil.
Braz J Med Biol Res. 2006 Feb;39(2):219-26. doi: 10.1590/s0100-879x2006000200008. Epub 2006 Feb 2.
Mitochondrial mutations are responsible for at least 1% of the cases of hereditary deafness, but the contribution of each mutation has not yet been defined in African-derived or native American genetic backgrounds. A total of 203 unselected hearing-impaired patients were screened for the presence of the mitochondrial mutation A1555G in the 12S rRNA gene and mutations in the tRNASer(UCN) gene in order to assess their frequency in the ethnically admixed Brazilian population. We found four individuals with A1555G mutation (2%), which is a frequency similar to those reported for European-derived populations in unselected samples. On the other hand, complete sequencing of the tRNASer(UCN) did not reveal reported pathogenic substitutions, namely A7445G, 7472insC, T7510C, or T7511C. Instead, other rare substitutions were found such as T1291C, A7569G, and G7444A. To evaluate the significance of these findings, 110 "European-Brazilians" and 190 "African-Brazilians" unrelated hearing controls were screened. The T1291C, A7569G and G7444A substitutions were each found in about 1% (2/190) of individuals of African ancestry, suggesting that they are probably polymorphic. Our results indicate that screening for the A1555G mutation is recommended among all Brazilian deaf patients, while testing for mutations in the tRNASer(UCN) gene should be considered only when other frequent deafness-causing mutations have been excluded or in the presence of a maternal transmission pattern.
线粒体突变导致了至少1%的遗传性耳聋病例,但在非洲裔或美洲原住民遗传背景中,每种突变的作用尚未明确。为了评估线粒体12S rRNA基因中的A1555G突变以及tRNASer(UCN)基因中的突变在种族混合的巴西人群中的频率,我们对203名未经选择的听力受损患者进行了筛查。我们发现4名个体存在A1555G突变(2%),这一频率与未选择样本中报道的欧洲裔人群相似。另一方面,tRNASer(UCN)的全序列分析未发现报道的致病性替代突变,即A7445G、7472insC、T7510C或T7511C。相反,发现了其他罕见替代突变,如T1291C、A7569G和G7444A。为了评估这些发现的意义,我们对110名“欧洲裔巴西人”和190名“非洲裔巴西人”非亲属听力正常对照者进行了筛查。T1291C、A7569G和G7444A替代突变在约1%(2/190)的非洲血统个体中均有发现,这表明它们可能是多态性的。我们的结果表明,建议对所有巴西耳聋患者进行A1555G突变筛查,而只有在排除其他常见致聋突变或存在母系遗传模式时,才应考虑检测tRNASer(UCN)基因中的突变。